National Research (US:NRC)2025-04-28 21:12Financial Performance - Revenue for Q1 2025 was $33,551,000, a decrease of 4.99% from $35,313,000 in Q1 2024[9] - Operating expenses declined to $24,955,000, down 6.02% from $26,553,000 in the previous year[9] - Net income for Q1 2025 was $5,787,000, a decrease of 9.00% compared to $6,359,000 in Q1 2024[9] Dividends and Share Repurchase - The Board declared a quarterly cash dividend of $0.12 per share, payable on July 11, 2025[5] - A new share repurchase program was approved to buy back up to one million additional shares[6] Assets and Equity - Cash and cash equivalents decreased to $2,502,000 from $4,233,000 at the end of 2024[11] - Total assets increased to $135,175,000 from $132,539,000 at the end of 2024[11] - Shareholders' equity decreased to $29,672,000 from $31,284,000 at the end of 2024[11] Growth and Expansion - Total recurring contract value increased sequentially for the second consecutive quarter, indicating revenue growth momentum[3] - The company is accelerating its sales force expansion to leverage broader product offerings[3]